This multi-functionalization allows CTL cells to relocate to EGFR-positive triple-negative breast cancer (TNBC) tumors while blocking the PD-L1/L2 immunosuppressive pathway on the tumor surface and activating the immune checkpoint stimulation signal (Cheng et al., 2022). Here, CD274 is linked to neoplasm.